International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease.

Saved in:
Bibliographic Details
Title: International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease.
Authors: Giani C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Baldi GG; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Ljevar S; Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Denu RA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Andelkovic V; Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, Australia., Han I; Department of Medical Oncology, Seoul National University Hospital, Seoul, South Korea., Brunello A; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy., Napolitano A; Department of Medical Oncology, The Royal Marsden NHS and Institute of Cancer Research, London, UK., Bhadri VA; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia., Scanferla R; Department of Orthopedics Oncology and Reconstructive Surgery, AOU Careggi, Florence, Italy., Garcia AS; Department of Medical Oncology, Sant Pau Hospital, Barcelona, Spain., Abreu MH; Department of Medical Oncology, Portuguese Institute of Oncology, Porto, Portugal., Campos F; Department of Medical Oncology, A.C.Camargo Cancer Center, São Paulo, Brazil., Ogura K; Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, Tokyo, Japan., Wong DD; Department of Anatomical Pathology, PathWest, Sir Charles Gairdner Hospital, Perth, Australia., Bae S; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Marquina G; Department of Medical Oncology, Hospital Clinico San Carlos, School of Medicine, UCM, IdISSC, EURACAN Referral Centre, Madrid, Spain., Mazzocca A; Department of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Yang V; Department of Medical Oncology, National Cancer Center, Singapore, Singapore., Nakazawa MS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Kim HS; Department of Orthopaedic Surgery, Seoul National University Hospital, Seoul, South Korea., Chiusole B; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy., Thway K; Department of Medical Oncology, The Royal Marsden NHS and Institute of Cancer Research, London, UK., Antonescu C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., Bellan E; Department of Integrated Diagnostics, Azienda Ospedale-Università Padova, Padova, Italy., Bovée JVMG; Department of Pathology, Leiden University, Medical Center, Leiden, The Netherlands., Davis JL; Department of Pathology, Indiana University School of Medicine, Indianapolis, USA., Dei Tos AP; Department of Integrated Diagnostics, Azienda Ospedale-Università Padova, Padova, Italy., Di Blasi E; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lazar AJ; Department of Pathology; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Sbaraglia M; Department of Integrated Diagnostics, Azienda Ospedale-Università Padova, Padova, Italy., Schaefer IM; Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, USA., Taverna S; Department of Technology Transfer Office, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Chen TW; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Miceli R; Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gronchi A; Department of Sarcoma Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Stacchiotti S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it.
Source: ESMO open [ESMO Open] 2026 Feb; Vol. 11 (2), pp. 106044. Date of Electronic Publication: 2026 Jan 20.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-7029
DOI:10.1016/j.esmoop.2025.106044